Literature DB >> 25263725

Toxic epidermal necrolysis in a neonate receiving fluconazole.

S Islam1, M Singer1, J A Kulhanjian1.   

Abstract

Toxic epidermal necrolysis (TEN) is a rare, life-threatening mucocutaneous condition, which may occur as an adverse reaction to a number of medications. The anitifungal agent, fluconazole, has been associated with TEN in limited reports, mainly in adults with HIV infection. We describe the case of a neonate with liver disease who developed TEN, presumably induced by fluconazole.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25263725     DOI： 10.1038/jp.2014.92

Source DB:  PubMed          Journal:  J Perinatol        ISSN： 0743-8346            Impact factor:   2.521


  10 in total

1.  Short-term and low-dose oral fluconazole treatment can cause Stevens-Johnson syndrome in HIV-negative patients.

Authors:  Efi Pasmatzi; Alexandra Monastirli; Sophia Georgiou; George Sgouros; Dionysios Tsambaos
Journal:  J Drugs Dermatol       Date:  2011-12       Impact factor: 2.114

2.  Stevens-Johnson syndrome after fluconazole.

Authors:  M J Gussenhoven; A Haak; J D Peereboom-Wynia; J W van 't Wout
Journal:  Lancet       Date:  1991-07-13       Impact factor: 79.321

Review 3.  Novel treatments for drug-induced toxic epidermal necrolysis (Lyell's syndrome).

Authors:  Philippe Paquet; Gérald E Piérard; Pascale Quatresooz
Journal:  Int Arch Allergy Immunol       Date:  2005-02-15       Impact factor: 2.749

4.  Stevens-Johnson syndrome due to prophylactic fluconazole in two patients with liver failure.

Authors:  E Craythorne; D Creamer
Journal:  Clin Exp Dermatol       Date:  2009-06-22       Impact factor: 3.470

Review 5.  Severe adverse cutaneous reactions to drugs.

Authors:  J C Roujeau; R S Stern
Journal:  N Engl J Med       Date:  1994-11-10       Impact factor: 91.245

6.  Fluconazole-induced toxic epidermal necrolysis in a patient with human immunodeficiency virus infection.

Authors:  A Azón-Masoliver; J Vilaplana
Journal:  Dermatology       Date:  1993       Impact factor: 5.366

7.  Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.

Authors:  Natacha Levi; Sylvie Bastuji-Garin; Maja Mockenhaupt; Jean-Claude Roujeau; Antoine Flahault; Judith P Kelly; Elvira Martin; David W Kaufman; Patrick Maison
Journal:  Pediatrics       Date:  2009-01-19       Impact factor: 7.124

8.  Fluconazole induced toxic epidermal necrolysis: a case report.

Authors:  Uchenna R Ofoma; Edward K Chapnick
Journal:  Cases J       Date:  2009-11-20

9.  Toxic epidermal necrolysis caused by fluconazole in a patient with human immunodeficiency virus infection.

Authors:  Jacob George; Arun Sharma; Ramakant Dixit; Naveen Chhabra; Smita Sharma
Journal:  J Pharmacol Pharmacother       Date:  2012-07

Review 10.  Safety of fluconazole in paediatrics: a systematic review.

Authors:  Oluwaseun Egunsola; Abiodun Adefurin; Apostolos Fakis; Evelyne Jacqz-Aigrain; Imti Choonara; Helen Sammons
Journal:  Eur J Clin Pharmacol       Date:  2013-01-17       Impact factor: 2.953
  10 in total
  2 in total

1.  A Retrospective Cohort Study of the Management and Outcomes of Children Hospitalized with Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis.

Authors:  James W Antoon; Jennifer L Goldman; Samir S Shah; Brian Lee
Journal:  J Allergy Clin Immunol Pract       Date:  2018-05-30

2.  Skin rash in the intensive care unit: Stevens-Johnson syndrome, toxic epidermal necrolysis, or a rare manifestation of a hidden cutaneous malignancy: A case report.

Authors:  Farah Al-Saffar; Saif Ibrahim; Pujan Patel; Rafik Jacob; Carlos Palacio; James Cury
Journal:  Mol Clin Oncol       Date:  2015-12-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.